Treatment of severe edema in children with nephrotic syndrome with diuretics alone - A prospective study

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 5, 2009, Pages 907-913

  Kapur, Gaurav ^a   Valentini, Rudolph P ^a   Imam, Abubakr A ^b   Mattoo, Tej K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIURETIC AGENT; FUROSEMIDE; SODIUM; SPIRONOLACTONE; UREA; ALBUMINOID;

ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DIURETIC THERAPY; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HUMAN; MALE; NEPHROTIC SYNDROME; PROSPECTIVE STUDY; SCHOOL CHILD; SODIUM EXCRETION; SODIUM URINE LEVEL; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY; ADOLESCENT; BLOOD VOLUME; DRUG EFFECT; HOSPITALIZATION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; URINE;

ADMINISTRATION, ORAL; ADOLESCENT; ALBUMINS; BLOOD VOLUME; CHILD; CHILD, PRESCHOOL; DIURETICS; EDEMA; FEMALE; FUROSEMIDE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALE; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SODIUM; SPIRONOLACTONE;

EID: 68549115644     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04390808     Document Type: Article

References (34)

1. Fliser D, Zurbruggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E: Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55: 629-634, 1999
2. Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y: Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32: 198-203, 1987
3. Kirchner KA, Voelker JR, Brater DC: Intratubular albumin blunts the response to furosemide. A mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther 252: 1097-1101, 1990
4. Sjostrom PA, Odlind BG, Beermann BA, Karlberg BE: Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. Eur J Clin Pharmacol 37: 173-180, 1989
5. Haws RM, Baum M: Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91: 1142-1146, 1993
6. Weiss RA, Schoeneman M, Greifer I: Treatment of severe nephrotic edema with albumin and furosemide. N Y State J Med 84: 384-386, 1984
7. Dorhout Mees EJ: Does it make sense to administer albumin to the patient with nephrotic oedema? Nephrol Dial Transplant 11: 1224-1226, 1996
8. DiBona GF, Herman PJ, Sawin LL: Neural control of renal function in edema-forming states. Am J Physiol 254: R1017-R1024, 1988
9. Dorhout EJ, Roos JC, Boer P, Yoe OH, Simatupang TA: Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med 67: 378-384, 1979
10. Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM: Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 71: 91-103, 1983
11. Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S: Nephrotic syndrome: Vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 91: 688-696, 1979
12. Schrier RW, Fassett RG: A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 53: 1111-1117, 1998
13. Atta MG, Choi MJ, Longenecker JC, Haymart M, Wu J, Nagajothi N, Racusen LC, Scheel PJ Jr, Brancati FL, Fine DM: Nephrotic range proteinuria and CD4 count as non-invasive indicators of HIV-associated nephropathy. Am J Med 118: 1288, 2005
14. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: 571-590, 1987
15. Holliday MA, Segar WE: The maintenance need for water in parenteral fluid therapy. Pediatrics 19: 823-832, 1957
16. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98: 561-564, 1981
17. Rose BD, Post TW: Meaning and application of urine chemistries. In: Clinical Physiology of Acid-Base and Electrolyte disorders, 5th ed., edited by Rose BD, Post TW, New York, McGraw Hill, 1994, pp 408-410
18. Donckerwolcke RA, France A, Raes A, Vande Walle J: Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol 59: 259-266, 2003
19. Vande Walle JG, Donckerwolcke RA, Koomans HA: Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10: 323-331, 1999
20. Dorhout Mees EJ, Geers AB, Koomans HA: Blood volume and sodium retention in the nephrotic syndrome: A controversial pathophysiological concept. Nephron 36: 201-211, 1984
21. Arnold WC: Efficacy of metolazone and furosemide in children with furosemide-resistant edema. Pediatrics 74: 872-875, 1984
22. Garin EH: A comparison of combinations of diuretics in nephrotic edema. Am J Dis Child 141: 769-771, 1987
23. Lang GR, Westenfelder C, Nascimento L, Dhupelia VB, Arruda JA, Kane RE: Metolazone and spironolactone in cirrhosis and the nephrotic syndrome. Clin Pharmacol Ther 21: 234-243, 1977
24. Lemieux G, Beauchemin M, Gougoux A, Vinay P: Treatment of nephrotic edema with bumetanide. CMAJ 125: 1111-1112, 1981
25. Paton RR, Kane RE: Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol 17: 243-251, 1977
26. Chalasani N, Gorski JC, Horlander JC Sr, Craven R, Hoen H, Maya J, Brater DC: Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12: 1010-1016, 2001
27. Yoshimura A, Ideura T, Iwasaki S, Taira T, Koshikawa S: Aggravation of minimal change nephrotic syndrome by administration of human albumin. Clin Nephrol 37: 109-114, 1992
28. Abbate M, Zoja C, Remuzzi G: How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17: 2974-2984, 2006
29. Vande Walle JG, Donckerwolcke RA: Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 16: 283-293, 2001
30. Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA: Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 346: 148-152, 1995
31. Rodriguez-Iturbe B, Colic D, Parra G, Gutkowska J: Atrial natriuretic factor in the acute nephritic and nephrotic syndromes. Kidney Int 38: 512-517, 1990
32. Tabel Y, Mungan I, Karakurt C, Kocak G, Gungor S: Is edema in minimal change disease of childhood really hypovolemic?. Int Urol Nephrol 40: 757-761, 2008
33. Sala C, Bedogna V, Gammaro L, Valvo E, Del Bo A, Morganti A: Central role of vasopressin in sodium/water retention in hypo- and hypervolemic nephrotic patients: A unifying hypothesis. J Nephrol 17: 653-657, 2004
34. Usberti M, Gazzotti RM, Poiesi C, D'Avanzo L, Ghielmi S: Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol 15: 38-47, 1995